Dexcom Inc. is a leading medical device company focused on the development and commercialization of continuous glucose monitoring (CGM) systems for people with diabetes. Its mission is to empower individuals to manage their diabetes more effectively through innovative technology that provides real-time glucose data. Dexcom's strategy emphasizes research and development to enhance its product offerings, expand market reach, and improve patient outcomes. The company's operations involve the design, manufacturing, and distribution of CGM devices that enable users to monitor their glucose levels seamlessly, ultimately aiming to improve the quality of life for those living with diabetes.

DEXCOM INC

DexCom is making notable advancements in the realm of continuous glucose monitoring (CGM) systems, particularly with its innovative integration of generative AI into glucose biosensing technology. As of February 2025, the company has emerged as the first CGM manufacturer to incorporate generative AI, which enhances the accuracy of glucose monitoring....

DexCom Pioneers Generative AI Integration in Glucose Monitoring with FDA-Approved Stelo CGM, Enhancing Diabetes Management and Accessibility